18 F-FDG PET/MRI vs MRI in patients with recurrent adenoid cystic carcinoma.
Julian KirchnerBenedikt M SchaarschmidtWolfgang SauerweinCornelius DeuschlDiana Arweiler-HarbeckLaura HoltmannVanessa StebnerLale UmutluGerald AntochVerena RuhlmannPublished in: Head & neck (2018)
18 F-FDG PET/MRI is superior to MRI in detecting local recurrence and metastases in patients with ACC of the head and neck. Especially concerning its negative predictive value, 18 F-FDG PET/MRI outperforms MRI.